Novartis AG: Diferență între versiuni
Admin (discuție | contribuții) (csv2wiki) |
Admin (discuție | contribuții) Fără descriere a modificării |
||
| (Nu s-a afișat o versiune intermediară efectuată de același utilizator) | |||
| Linia 1: | Linia 1: | ||
Pagina dedicata companiei Novartis AG listata cu simbolul US.NVS | Pagina dedicata companiei Novartis AG listata cu simbolul US.NVS | ||
| Linia 5: | Linia 4: | ||
Novartis AG (https://www.novartis.com/) is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars. | Novartis AG (https://www.novartis.com/) is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars. | ||
==Grafic actiuni companie== | |||
<iframe key="tradeville" path="graficSimbol/US.NVS" /> | |||
==Ultimele stiri despre Novartis AG (US.NVS)== | ==Ultimele stiri despre Novartis AG (US.NVS)== | ||
| Linia 13: | Linia 14: | ||
addfirstcategorydate=false | addfirstcategorydate=false | ||
</dynamicpagelist> | </dynamicpagelist> | ||
[[Categorie:US.NVS]][[Categorie:Stiri despre companii]] | [[Categorie:US.NVS]][[Categorie:Stiri despre companii]] | ||
Versiunea curentă din 18 septembrie 2024 20:17
Pagina dedicata companiei Novartis AG listata cu simbolul US.NVS
Descriere companieModificare
Novartis AG (https://www.novartis.com/) is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.
Grafic actiuni companieModificare
Ultimele stiri despre Novartis AG (US.NVS)Modificare
- Focus pe investitii si digitalizare - 10 decembrie 2025
- Constructiile accelereaza puternic - 21 noiembrie 2025
- Crestere temporara pentru piata auto - 12 august 2025
- Cifra de afaceri din industrie - 18 iulie 2025
- Subocuparea in anul 2024 in Romania - 30 aprilie 2025
- Fidelis, Valentine’s Day edition - 03 februarie 2025
- Lucrarile de constructii in luna iulie - 19 septembrie 2024
- Fidelis pierde din popularitate - 05 octombrie 2023
- Mai putine locuinte date in folosinta - 13 iunie 2023
- Novartis vrea un spin off cu Sandoz pentru a crea un lider european pentru medicamente generice - 25 august 2022